BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huang F, Wu G, Yang K. Oligometastasis and oligo-recurrence: more than a mirage. Radiat Oncol 2014;9:230. [PMID: 25359216 DOI: 10.1186/s13014-014-0230-6] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 4.6] [Reference Citation Analysis]
Number Citing Articles
1 Zhao Y, Li J, Li D, Wang Z, Zhao J, Wu X, Sun Q, Lin PP, Plum P, Damanakis A, Gebauer F, Zhou M, Zhang Z, Schlösser H, Jauch KW, Nelson PJ, Bruns CJ. Tumour biology and multidisciplinary strategies of oligometastasis in gastrointestinal cancers.Semin Cancer Biol. 2020;60:334-343. [PMID: 31445220 DOI: 10.1016/j.semcancer.2019.08.026] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
2 Negoi I, Runcanu A, Paun S, Negoi RI, Beuran M. Resection of Large Metachronous Liver Metastasis with Gastric Origin: Case Report and Review of the Literature. Cureus 2016;8:e814. [PMID: 27843732 DOI: 10.7759/cureus.814] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
3 AlSendi M, O'Reilly D, Zeidan YH, Kelly CM. Oligometastatic breast cancer: Are we there yet? Int J Cancer 2021;149:1520-8. [PMID: 34013530 DOI: 10.1002/ijc.33693] [Reference Citation Analysis]
4 Achard V, Bottero M, Rouzaud M, Lancia A, Scorsetti M, Filippi AR, Franzese C, Jereczek-Fossa BA, Ingrosso G, Ost P, Zilli T. Radiotherapy treatment volumes for oligorecurrent nodal prostate cancer: a systematic review. Acta Oncol 2020;59:1224-34. [PMID: 32536241 DOI: 10.1080/0284186X.2020.1775291] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
5 Albergotti WG, Abberbock S, Mathews F, Ferris RL, Johnson JT, Duvvuri U, Kim S. Oligometastatic status as predictor of survival in metastatic human papillomavirus-positive oropharyngeal carcinoma. Head Neck 2018;40:1685-90. [PMID: 29756301 DOI: 10.1002/hed.25171] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
6 Guida M, Bartolomeo N, De Risi I, Fucci L, Armenio A, Filannino R, Ruggieri E, Macina F, Traversa M, Nardone A, Figliuolo F, De Luca F, Mele F, Tommasi S, Strippoli S. The Management of Oligoprogression in the Landscape of New Therapies for Metastatic Melanoma. Cancers (Basel) 2019;11:E1559. [PMID: 31615127 DOI: 10.3390/cancers11101559] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
7 O'Sullivan S, Cagney DN. The emerging role of stereotactic radiotherapy in gastrointestinal malignancies: a review of the literature and analysis from the Irish perspective. Ir J Med Sci 2018;187:887-94. [PMID: 29423821 DOI: 10.1007/s11845-018-1755-8] [Reference Citation Analysis]
8 Lu X, Gu W, Zhang H, Zhu Y, Shi G, Ye D. Oligometastatic state predicts a favorable outcome for renal cell carcinoma patients with bone metastasis under the treatment of sunitinib. Oncotarget 2016;7:26879-87. [PMID: 27058898 DOI: 10.18632/oncotarget.8568] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
9 Sun Z, Zhou S, Tang J, Ye T, Li J, Liu D, Zhou J, Wang J, Rosie Xing H. Sec23a mediates miR-200c augmented oligometastatic to polymetastatic progression. EBioMedicine 2018;37:47-55. [PMID: 30301603 DOI: 10.1016/j.ebiom.2018.10.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
10 Molla M, Fernandez-Plana J, Albiol S, Fondevila C, Vollmer I, Cases C, Garcia-Criado A, Capdevila J, Conill C, Fundora Y, Fernandez-Martos C, Pineda E. Limited Liver or Lung Colorectal Cancer Metastases. Systemic Treatment, Surgery, Ablation or SBRT. J Clin Med 2021;10:2131. [PMID: 34069240 DOI: 10.3390/jcm10102131] [Reference Citation Analysis]
11 Lovecek M, Skalicky P, Chudacek J, Szkorupa M, Svebisova H, Lemstrova R, Ehrmann J, Melichar B, Yogeswara T, Klos D, Vrba R, Havlik R, Mohelnikova-Duchonova B. Different clinical presentations of metachronous pulmonary metastases after resection of pancreatic ductal adenocarcinoma: Retrospective study and review of the literature. World J Gastroenterol 2017; 23(35): 6420-6428 [PMID: 29085191 DOI: 10.3748/wjg.v23.i35.6420] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
12 Al-Shafa F, Arifin AJ, Rodrigues GB, Palma DA, Louie AV. A Review of Ongoing Trials of Stereotactic Ablative Radiotherapy for Oligometastatic Cancers: Where Will the Evidence Lead? Front Oncol 2019;9:543. [PMID: 31293976 DOI: 10.3389/fonc.2019.00543] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 10.7] [Reference Citation Analysis]
13 Sakisuka T, Kashiwagi N, Doi H, Takahashi H, Arisawa A, Matsuo C, Masuda Y, Inohara H, Sato K, Outani H, Ishii K, Tomiyama N. Prognostic factors for bone metastases from head and neck squamous cell carcinoma: A case series of 97 patients. Mol Clin Oncol 2021;15:246. [PMID: 34650813 DOI: 10.3892/mco.2021.2408] [Reference Citation Analysis]
14 Ettaieb MHT, Duker JC, Feelders RA, Corssmit EPM, Menke-van der Houven van Oordt CW, Timmers HJLM, Kerstens MN, Wilmink JW, Zelissen PM, Havekes B, Haak HR. Synchronous vs. Metachronous Metastases in Adrenocortical Carcinoma: an Analysis of the Dutch Adrenal Network. HORM CANC 2016;7:336-44. [DOI: 10.1007/s12672-016-0270-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
15 Hishida T, Yoshida J, Aokage K, Nagai K, Tsuboi M. Postoperative oligo-recurrence of non-small-cell lung cancer: clinical features and survival†. Eur J Cardiothorac Surg 2016;49:847-53. [PMID: 26201958 DOI: 10.1093/ejcts/ezv249] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
16 Murakawa T. Past, present, and future perspectives of pulmonary metastasectomy for patients with advanced colorectal cancer. Surg Today 2021;51:204-11. [PMID: 32857252 DOI: 10.1007/s00595-020-02119-y] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Otake S, Goto T. Stereotactic Radiotherapy for Oligometastasis. Cancers (Basel) 2019;11:E133. [PMID: 30678111 DOI: 10.3390/cancers11020133] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 7.3] [Reference Citation Analysis]
18 Nicosia L, Agolli L, Reverberi C, De Sanctis V, Marinelli L, Minniti G, Di Muzio J, Valeriani M, Osti MF. Salvage radiotherapy with simultaneous integrated boost in non small-cell lung cancer patients with mediastinal relapse after surgery: a pilot study. Radiat Oncol 2018;13:207. [PMID: 30352607 DOI: 10.1186/s13014-018-1155-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
19 Matsushita H, Jingu K, Umezawa R, Yamamoto T, Ishikawa Y, Takahashi N, Katagiri Y, Kadoya N. Stereotactic Radiotherapy for Oligometastases in Lymph Nodes-A Review. Technol Cancer Res Treat 2018;17:1533033818803597. [PMID: 30352542 DOI: 10.1177/1533033818803597] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
20 Westphal T, Gampenrieder SP, Rinnerthaler G, Greil R. Cure in metastatic breast cancer. Memo 2018;11:172-9. [PMID: 30220923 DOI: 10.1007/s12254-018-0426-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
21 Chee J, Liu X, Eu D, Loh T, Ho F, Wong LC, Tham I, Tan CS, Goh BC, Lim CM. Defining a cohort of oligometastatic nasopharyngeal carcinoma patients with improved clinical outcomes. Head & Neck 2020;42:945-54. [DOI: 10.1002/hed.26061] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
22 Santini D, Ratta R, Pantano F, De Lisi D, Maruzzo M, Galli L, Biasco E, Farnesi A, Buti S, Sternberg CN, Cerbone L, Di Lorenzo G, Spoto S, Sterpi M, De Giorgi U, Berardi R, Torniai M, Camerini A, Massari F, Procopio G, Tonini G. Outcome of oligoprogressing metastatic renal cell carcinoma patients treated with locoregional therapy: a multicenter retrospective analysis. Oncotarget 2017;8:100708-16. [PMID: 29246014 DOI: 10.18632/oncotarget.20022] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
23 Mat Lazim N, Elliott M, Wykes J, Clark J. Oligometastases in head and neck carcinoma and their impact on management. ANZ J Surg 2021. [PMID: 33634950 DOI: 10.1111/ans.16622] [Reference Citation Analysis]
24 Barberi V, Pietragalla A, Franceschini G, Marazzi F, Paris I, Cognetti F, Masetti R, Scambia G, Fabi A. Oligometastatic Breast Cancer: How to Manage It? J Pers Med 2021;11:532. [PMID: 34207648 DOI: 10.3390/jpm11060532] [Reference Citation Analysis]
25 Gorayski P, Burmeister B, Foote M. Radiotherapy for cutaneous melanoma: current and future applications. Future Oncology 2015;11:525-34. [DOI: 10.2217/fon.14.300] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
26 Reyes DK, Pienta KJ. The biology and treatment of oligometastatic cancer. Oncotarget 2015;6:8491-524. [PMID: 25940699 DOI: 10.18632/oncotarget.3455] [Cited by in Crossref: 151] [Cited by in F6Publishing: 143] [Article Influence: 25.2] [Reference Citation Analysis]
27 Wang WJ, Chiou JF, Huang Y. Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy. J Vis Exp 2018. [PMID: 29806826 DOI: 10.3791/57050] [Reference Citation Analysis]
28 Soldatov A, von Klot CA, Walacides D, Derlin T, Bengel FM, Ross TL, Wester H, Derlin K, Kuczyk MA, Christiansen H, Henkenberens C. Patterns of Progression After 68Ga-PSMA-Ligand PET/CT-Guided Radiation Therapy for Recurrent Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics 2019;103:95-104. [DOI: 10.1016/j.ijrobp.2018.08.066] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 10.3] [Reference Citation Analysis]
29 Ruiz A, Sebagh M, Wicherts DA, Castro-Benitez C, van Hillegersberg R, Paule B, Castaing D, Vibert E, Cunha AS, Cherqui D, Morère JF, Adam R. Long-term survival and cure model following liver resection for breast cancer metastases. Breast Cancer Res Treat 2018;170:89-100. [PMID: 29464535 DOI: 10.1007/s10549-018-4714-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
30 Guerrero E, Ahmed M. The role of stereotactic ablative radiotherapy (SBRT) in the management of oligometastatic non small cell lung cancer. Lung Cancer 2016;92:22-8. [PMID: 26775592 DOI: 10.1016/j.lungcan.2015.11.015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
31 Klement RJ. Radiobiological parameters of liver and lung metastases derived from tumor control data of 3719 metastases. Radiother Oncol 2017;123:218-26. [PMID: 28363484 DOI: 10.1016/j.radonc.2017.03.014] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]
32 Parvinian A, Schmitz JJ, Welch BT, Atwell TD, Morris JM, Woodrum DA, Kurup AN. A Single-Institution Experience in Percutaneous Image-Guided Cryoablation of Lymph Node Metastases. AJR Am J Roentgenol 2021;217:152-6. [PMID: 33852333 DOI: 10.2214/AJR.20.22861] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Coombe R, Lisy K, Campbell J, Perry G, Prasannan S. Survival outcomes following aggressive treatment of oligometastatic breast cancer: a systematic review protocol. JBI Database System Rev Implement Rep 2017;15:2013-9. [PMID: 28800049 DOI: 10.11124/JBISRIR-2016-002954] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
34 Treasure T, Macbeth F. Is Surgery Warranted for Oligometastatic Disease? Thorac Surg Clin 2016;26:79-90. [PMID: 26611513 DOI: 10.1016/j.thorsurg.2015.09.010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
35 Segarra Vidal B, Cañete Mota S, Andrade Cadena P, Llueca Abella A. Adenoid cystic carcinoma of the Bartholin's gland. Int J Gynecol Cancer 2021;31:292-8. [PMID: 33214217 DOI: 10.1136/ijgc-2020-002183] [Reference Citation Analysis]
36 Savir-Baruch B, Choyke PL, Rowe SP, Schuster DM, Subramaniam RM, Jadvar H. Role of 18F-Fluciclovine and Prostate-Specific Membrane Antigen PET/CT in Guiding Management of Oligometastatic Prostate Cancer: AJR Expert Panel Narrative Review. AJR Am J Roentgenol 2021;216:851-9. [PMID: 33206564 DOI: 10.2214/AJR.20.24711] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
37 Autrusseau PA, Cazzato RL, Koch G, Ramamurthy N, Auloge P, De Marini P, Lipsker D, Gangi A, Garnon J. Freezing Nodal Disease: Local Control Following Percutaneous Image-Guided Cryoablation of Locoregional and Distant Lymph Node Oligometastases: A 10-Year, Single-Center Experience. J Vasc Interv Radiol 2021:S1051-0443(21)01213-6. [PMID: 34271190 DOI: 10.1016/j.jvir.2021.07.002] [Reference Citation Analysis]
38 Donini M, Buti S, Massari F, Mollica V, Rizzo A, Montironi R, Bersanelli M, Santoni M. Management of oligometastatic and oligoprogressive renal cell carcinoma: state of the art and future directions. Expert Rev Anticancer Ther 2020;20:491-501. [PMID: 32479120 DOI: 10.1080/14737140.2020.1770601] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
39 Kelly P, Ma Z, Baidas S, Moroose R, Shah N, Dagan R, Mamounas E, Rineer J. Patterns of Progression in Metastatic Estrogen Receptor Positive Breast Cancer: An Argument for Local Therapy. Int J Breast Cancer 2017;2017:1367159. [PMID: 29147583 DOI: 10.1155/2017/1367159] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]